Geovax Labs Inc (FRA:E8LA)
€ 0.1999 0 (0%) Market Cap: 3.98 Mil Enterprise Value: 3.27 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 34/100

Q3 2021 GeoVax Labs Inc Earnings Call Transcript

Nov 11, 2021 / 09:30PM GMT
Release Date Price: €50.7 (-3.43%)
Operator

Good afternoon, and welcome everyone to the GeoVax third-quarter 2021 corporate update call. I am Rocco with Chorus Call and will facilitate today's call. With me are David Dodd, Chairman and CEO; Mark Reynolds, Chief Financial Officer; Mark Newman, Ph.D., Chief Scientific Officer; John Sharkey, Ph.D., Head, Business Development; and Don Diamond, Ph.D., Professor, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope.

(Operator Instructions) Please note this event is being recorded. I would now like to turn the conference over to Jules Abraham of CORE IR, who will provide a forward-looking statement regarding this call and information herein.

Jules Abraham
CORE IR - IR

Thank you, Rocco, and good afternoon everyone. Please note the following: certain statements in this presentation may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances.

Actual

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot